Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study

Background: Several issues on neoadjuvant imatinib therapy remain controversial despite its widespread application for rectal gastrointestinal stromal tumors (GIST). We aimed to describe the clinicopathological characteristics of this specific population, and compare the surgical and oncologic outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weihao, Li, Xinyue, Yu, Kun, Xiao, Binyi, Peng, Jianhong, Zhang, Rongxin, Zhang, Lingfang, Wang, Kun, Pan, Zhizhong, Li, Cong, Wu, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552070/
https://www.ncbi.nlm.nih.gov/pubmed/36238544
http://dx.doi.org/10.3389/fphar.2022.950101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552070/
https://www.ncbi.nlm.nih.gov/pubmed/36238544
http://dx.doi.org/10.3389/fphar.2022.950101

Ejemplares similares